XML 54 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation And Employee Benefit Plans (Tables)
12 Months Ended
Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Assumptions Used In The Black-Scholes Valuation Model
 
 
ESPP Purchase Rights
 
 
Year Ended March 31,
 
 
2019
 
2018
 
2017
Risk-free interest rate
 
2.2 - 2.5%

 
1.1 - 2.0%

 
0.5 - 0.8%

Expected volatility
 
29 - 33%

 
28 - 30%

 
25 - 32%

Weighted-average volatility
 
33
%
 
29
%
 
27
%
Expected term
 
6 - 12 months

 
6 - 12 months

 
6 - 12 months

Expected dividends
 
None

 
None

 
None

Schedule Of Assumptions Used In Monte-Carlo Simulation Model
The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows: 
 
Year Ended March 31,
 
2019
 
2018
 
2017
Risk-free interest rate
2.6
%
 
1.5 - 1.6%

 
0.8
%
Expected volatility
16 - 47%

 
17 - 46%

 
16 - 57%

Weighted-average volatility
28
%
 
28
%
 
29
%
Expected dividends
None

 
None

 
None

Schedule Of Stock-Based Compensation Expense By Statement Of Operations

 
 
Year Ended March 31,
 
 
2019
 
2018
 
2017
Cost of revenue
 
$
4

 
$
3

 
$
3

Research and development
 
184

 
146

 
109

Marketing and sales
 
33

 
32

 
31

General and administrative
 
63

 
61

 
53

Stock-based compensation expense
 
$
284

 
$
242

 
$
196

Summary Of Outstanding And Exercisable Stock Options
The following table summarizes outstanding and exercisable stock options as of March 31, 2019: 
 
 
Options Outstanding and Exercisable
Range of
Exercise Prices
 
Number
of Shares
(in thousands)
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Weighted-
Average
Exercise
Prices
 
Potential
Dilution
$11.53 - $22.42
 
52

 
0.62
 
$
19.99

 
%
26.25 - 26.25
 
670

 
4.59
 
26.25

 
0.3
%
33.60 - 37.12
 
653

 
5.16
 
35.97

 
0.2
%
$11.53 - $37.12
 
1,375

 
4.71
 
$
30.63

 
0.5
%
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]
The following table summarizes our ESPP activity for fiscal years ended March 31, 2019, 2018 and 2017: 
 
 
Shares Issued
(in millions)
 
Exercise Prices for Purchase Rights
 
Weighted-Average Fair Values of Purchase Rights
Fiscal Year 2017
 
0.7

 
$54.60 - $67.56
 
$
17.93

Fiscal Year 2018
 
0.6

 
$67.56 - $99.82
 
$
21.57

Fiscal Year 2019
 
0.5

 
$89.46 - $107.51
 
$
31.88

Shares Repurchased and Retired

The following table summarizes total shares repurchased during fiscal years 2019, 2018, and 2017:
 
May 2015 Program
 
May 2017 Program
 
May 2018 Program
 
Total
(In millions)
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
Fiscal Year 2017
6.5

 
$
508

 

 
$

 

 
$

 
6.5

 
$
508

Fiscal Year 2018
0.3

 
$
31

 
5.0

 
$
570

 

 
$

 
5.3

 
$
601

Fiscal Year 2019

 
$

 
0.6

 
$
76

 
10.4

 
$
1,116

 
11.0

 
$
1,192

Employee Stock Option [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the fiscal year ended March 31, 2019: 
 
 
Options
(in thousands)
 
Weighted-
Average
Exercise Prices
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2018
 
1,615

 
$
30.28

 
 
 
 
Granted
 
5

 
106.55

 
 
 
 
Exercised
 
(245
)
 
30.00

 
 
 
 
Forfeited, cancelled or expired
 

 

 
 
 
 
Outstanding as of March 31, 2019
 
1,375

 
$
30.63

 
4.71
 
$
98

Vested and expected to vest
 
1,375

 
$
30.63

 
4.71
 
$
98

Exercisable as of March 31, 2019
 
1,375

 
$
30.63

 
4.71
 
$
98

Restricted Stock Rights [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
Each restricted stock unit granted reduces the number of shares available for grant by 1.43 shares under our Equity Plan. The following table summarizes our restricted stock units activity, excluding performance-based and market-based restricted stock unit activity which is discussed below, for the fiscal year ended March 31, 2019: 
 
 
Restricted
Stock Units
(in thousands)
 
Weighted-
Average Grant
Date Fair Values
Outstanding as of March 31, 2018
 
5,948

 
$
94.57

Granted
 
2,169

 
128.76

Vested
 
(2,541
)
 
88.09

Forfeited or cancelled
 
(616
)
 
109.09

Outstanding as of March 31, 2019
 
4,960

 
$
111.03


Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
 
Performance-
Based Restricted
Stock Units
(in thousands)
 
Weighted-
Average Grant
Date Fair Value
Outstanding as of March 31, 2018
796

 
$
110.51

Granted

 

Forfeited or cancelled
(217
)
 
110.51

Outstanding as of March 31, 2019
579

 
$
110.51

Market Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
:
 
 
Market-Based
Restricted  Stock
Units
(in thousands)
 
Weighted-
Average  Grant
Date Fair Value
Outstanding as of March 31, 2018
 
1,342

 
$
118.35

Granted
 
573

 
185.24

Vested
 
(415
)
 
98.48

Forfeited or cancelled
 
(542
)
 
136.91

Outstanding as of March 31, 2019
 
958

 
$
156.49